Amneal Pharmaceuticals (AMRX) to Move to Nasdaq
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/3/2026
- Wall Street ends sharply higher as Waller remarks ease rate hike fears
- Fed’s Waller open to September rate hold - if disinflation holds up
- Broadcom raises AI chip forecast as Big Tech keeps writing bigger checks
- Nvidia to acquire AI platform Hugging Face in landmark $12.9B deal
- Tesla to unveil Cybercab Texas today, details are few
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
Amneal Announces Move to Nasdaq
December 15, 2023 4:05 PM EST- Nasdaq move will be effective on December 27, 2023
BRIDGEWATER, N.J.--(BUSINESS WIRE)-- Amneal Pharmaceuticals, Inc. (Amneal) (NYSE: AMRX) today announced that it will transfer its stock exchange listing to the Nasdaq Stock Market (Nasdaq) from the New York Stock Exchange (NYSE). The Company expects the Nasdaq listing to occur on December 27, 2023 and will continue to trade under the current symbol AMRX. Upon transferring, Amneal will become part of the Nasdaq Composite Index and Nasdaq Biotechnology Index.
We are pleased to join the community of global pharmaceutical companies listed on Nasdaq. We... More
